APA (7th ed.) Citation

Forbes, N., Bosch, J., & Eikelboom, J. W. (2024). Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply. Alimentary Pharmacology & Therapeutics, 60(11/12), 1652. https://doi.org/10.1111/apt.18317

Chicago Style (17th ed.) Citation

Forbes, Nauzer, Jackie Bosch, and John W. Eikelboom. "Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 11/12 (2024): 1652. https://doi.org/10.1111/apt.18317.

MLA (9th ed.) Citation

Forbes, Nauzer, et al. "Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 11/12, 2024, p. 1652, https://doi.org/10.1111/apt.18317.